Provided by Tiger Trade Technology Pte. Ltd.

Pulse Biosciences

55.00
+2.033.83%
Volume:136.85K
Turnover:7.43M
Market Cap:3.92B
PE:-46.78
High:56.21
Open:52.18
Low:51.30
Close:52.97
52wk High:58.90
52wk Low:12.56
Shares:71.32M
Float Shares:20.81M
Volume Ratio:0.93
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1756
EPS(LYR):-1.0800
ROE:-78.49%
ROA:-44.34%
PB:39.42
PE(LYR):-50.93

Loading ...

Earnings Flash (PLSE) Pulse Biosciences Posts Q1 Loss $0.27 a Share, vs. FactSet Est of $0.32 Loss

MT Newswires Live
·
May 04

Pulse Biosciences Q1 FY26 net loss widens to $18.6 million; revenue rises to $401,000

Reuters
·
May 04

BRIEF-Pulse Biosciences Q1 Net Income USD -18.581 Million

Reuters
·
May 04

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 04

Pulse Biosciences Q1 EPS USD -0.27

THOMSON REUTERS
·
May 04

Pulse Biosciences Reports Strong nPulse Atrial Fibrillation Data

TIPRANKS
·
Apr 27

Pulse Biosciences reports 96% one-year success in nPulse AF catheter study

Reuters
·
Apr 27

Pulse Biosciences presents clinical data from nPulse Cardiac Catheter System

TIPRANKS
·
Apr 27

BRIEF-Pulse Biosciences Announces Positive Clinical Data From Npulse Cardiac Catheter System

Reuters
·
Apr 26

Pulse Biosciences nPulse catheter posts 96% AF ablation success at one year

Reuters
·
Apr 26

Pulse Biosciences to feature nPulse tech at Heart Rhythm Society meeting

TIPRANKS
·
Apr 20

Pulse Biosciences to present one-year nsPFA atrial fibrillation study outcomes at HRS 2026

Reuters
·
Apr 20

Pulse Biosciences to host analyst event after Heart Rhythm Society late-breaking data presentation

Reuters
·
Apr 17

Pulse Biosciences Targets Thyroid Nodules With New Device Study, Eyeing a Minimally Invasive Niche

TIPRANKS
·
Apr 17

Pulse Biosciences Updates 2026 Cardiac Ablation Strategy

TIPRANKS
·
Apr 16

Is Pulse Biosciences’ New Leadership Structure Reframing the PLSE Cardiac Therapy Commercialization Story?

Simply Wall St.
·
Apr 12

BRIEF-Pulse Biosciences Strengthens Executive Leadership Team

Reuters
·
Apr 09

Pulse Biosciences names Liane Teplitsky chief operating officer

Reuters
·
Apr 09

Affluent Medical names Anne Lange to board, replaces Soad El Gazaoui

Reuters
·
Apr 09

Pulse Biosciences Launches Pivotal NANOPULSE-AF Clinical Study

TIPRANKS
·
Apr 07